Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events: results of a long-term follow-up study in routine clinical care

被引:0
|
作者
Dietrich Rothenbacher
Michael M Hoffmann
Lutz P Breitling
Iris Rajman
Wolfgang Koenig
Hermann Brenner
机构
[1] Ulm University,Institute of Epidemiology and Medical Biometry
[2] German Cancer Research Center,Division of Clinical Epidemiology & Aging Research
[3] University Medical Center Freiburg,Department of Clinical Chemistry
[4] Novartis Institute of Biomedical Research,Department of Internal Medicine II
[5] University of Ulm Medical Center,Cardiology
来源
BMC Cardiovascular Disorders | / 13卷
关键词
Percutaneous Coronary Intervention; Clopidogrel; Coronary Artery Bypass Grafting; Prasugrel; Ticagrelor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 33 条
  • [1] Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events: results of a long-term follow-up study in routine clinical care
    Rothenbacher, Dietrich
    Hoffmann, Michael M.
    Breitling, Lutz P.
    Rajman, Iris
    Koenig, Wolfgang
    Brenner, Hermann
    BMC CARDIOVASCULAR DISORDERS, 2013, 13
  • [2] Relationship between cytochrome P450 2C19 polymorphism and cardiovascular events in Indonesian patients with coronary artery disease
    Mappiare, M.
    Amir, M.
    Kabo, P.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2017, 19 (0E) : E22 - E22
  • [3] Cytochrome P450 2C19 polymorphism in Iranian patients with coronary artery disease
    Akhlaghi, Arash
    Shirani, Shahin
    Ziaie, Naghmeh
    Pirhaji, Omid
    Yaran, Majid
    Shahverdi, Golnoosh
    Sarrafzadegan, Nizal
    Khosravi, Alireza
    Khosravi, Elham
    ARYA ATHEROSCLEROSIS, 2011, 7 (03) : 106 - 110
  • [4] Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel
    Jin, Bo
    Ni, Huan-Chun
    Shen, Wei
    Li, Jian
    Shi, Hai-Ming
    Li, Yong
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (03) : 1697 - 1702
  • [5] Effect of cytochrome P450 2C19 (CYP2C19) gene polymorphism and clopidogrel reactivity on long term prognosis of patients with coronary heart disease after PCI
    Hu, Cheng-Yan
    Wang, Yan-Ling
    Fan, Zhen-Xing
    Sun, Xi-Peng
    Wang, Shuai
    Liu, Zhi
    JOURNAL OF GERIATRIC CARDIOLOGY, 2024, 21 (01) : 90 - 103
  • [6] Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel
    Bo Jin
    Huan-Chun Ni
    Wei Shen
    Jian Li
    Hai-Ming Shi
    Yong Li
    Molecular Biology Reports, 2011, 38 : 1697 - 1702
  • [7] The Cytochrome P450 2C19 Polymorphism Associated with Major Adverse Cardiovascular Events Risk in Kazak Patients Undergoing Percutaneous Coronary Intervention and Receiving Clopidogrel
    Wang, Tingting
    Feng, Jie
    Zhou, Liying
    Zhao, Ting
    Zhang, Huilan
    Shen, Hao
    Xu, Li
    Sun, Li
    Wu, Jianhua
    Li, Hongjian
    Yu, Luhai
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (02) : 196 - 204
  • [8] α2A -Adrenergic Receptor Polymorphism Potentiates Platelet Reactivity in Patients With Stable Coronary Artery Disease Carrying the Cytochrome P450 2C19*2 Genetic Variant
    Peace, Aaron J.
    Mangiacapra, Fabio
    Bailleul, Els
    Delrue, Leen
    Dierickx, Karen
    Conte, Micaela
    Puymirat, Etienne
    Fraeymans, Anne Lies
    Meeus, Pieter
    Bartunek, Jozef
    Volpe, Massimo
    Barbato, Emanuele
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (06) : 1314 - 1319
  • [9] Relationship between recurrent ischemic events in cerebrovascular disease and cytochrome P450 2C19 gene polymorphism on the basis of thrombelastography
    Liu, Jiaming
    Zhao, Yulong
    Chen, He
    Yang, Fangyu
    Chen, Ligang
    Hao, Guangzhi
    Gao, Xu
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (01) : 240 - 249
  • [10] Cytochrome P450 2C19☆2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis
    Sofi, F.
    Giusti, B.
    Marcucci, R.
    Gori, A. M.
    Abbate, R.
    Gensini, G. F.
    PHARMACOGENOMICS JOURNAL, 2011, 11 (03) : 199 - 206